We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+1.45%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$77.7B
AUM Growth
+$28.1B
Cap. Flow
+$27.7B
Cap. Flow %
35.64%
Top 10 Hldgs %
8.03%
Holding
3,834
New
1,974
Increased
1,386
Reduced
336
Closed
47

Sector Composition

Rank Sector Weight
1 Technology 15.99%
2 Financials 14.9%
3 Industrials 12.22%
4 Consumer Discretionary 10.07%
5 Healthcare 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDXG
3451
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$5K ﹤0.01%
+639
New +$4.99K
HOS
3452
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$5K ﹤0.01%
+6,399
New +$5.54K
SRAX
3453
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$5K ﹤0.01%
+2,023
New +$7.32K
TRNX
3454
DELISTED
Taronis Technologies, Inc. Common Stock
TRNX
$5K ﹤0.01%
+2,810
New +$5.85K
LLEX
3455
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
$5K ﹤0.01%
+15,692
New +$6.04K
RNWK
3456
DELISTED
RealNetworks Inc
RNWK
$5K ﹤0.01%
+3,036
New +$4.95K
AIRI icon
3457
Air Industries Group
AIRI
$12.8M
$4K ﹤0.01%
+330
New +$3.87K
APVO icon
3458
Aptevo Therapeutics
APVO
$5.21M
0
AYTU icon
3459
AYTU BioPharma
AYTU
$25.3M
$4K ﹤0.01%
+15
New +$4.52K
BMRA icon
3460
Biomerica
BMRA
$4.98M
$4K ﹤0.01%
+168
New +$4.08K
BWEN icon
3461
Broadwind
BWEN
$109M
$4K ﹤0.01%
+2,564
New +$4.92K
CATX icon
3462
Perspective Therapeutics
CATX
$342M
$4K ﹤0.01%
+1,204
New +$4.36K
CLDX icon
3463
Celldex Therapeutics
CLDX
$3.28B
$4K ﹤0.01%
+1,796
New +$4.16K
CLSD
3464
DELISTED
Clearside Biomedical
CLSD
$4K ﹤0.01%
+379
New +$5.43K
CODA icon
3465
Coda Octopus Group
CODA
$120M
$4K ﹤0.01%
+512
New +$5.55K
EDUC icon
3466
Educational Development Corp
EDUC
$11.8M
$4K ﹤0.01%
+701
New +$4.47K
FGNX
3467
FG Nexus Inc
FGNX
$38.7M
$4K ﹤0.01%
+7
New +$4.35K
GROW icon
3468
US Global Investors
GROW
$38.5M
$4K ﹤0.01%
+1,948
New +$3.71K
HDSN
3469
Hudson Technologies
HDSN
$235M
$4K ﹤0.01%
+5,716
New +$3.54K
IRIX icon
3470
IRIDEX
IRIX
$14.5M
$4K ﹤0.01%
+1,986
New +$5.82K
JRSH icon
3471
Jerash Holdings
JRSH
$63.5M
$4K ﹤0.01%
+587
New +$4.23K
JVA icon
3472
Coffee Holding Co
JVA
$20M
$4K ﹤0.01%
+916
New +$3.71K
LCNB icon
3473
LCNB Corp
LCNB
$283M
$4K ﹤0.01%
226
-592
-72% -$10.4K
LPTH icon
3474
Lightpath Technologies
LPTH
$820M
$4K ﹤0.01%
+4,201
New +$3.35K
LRMR icon
3475
Larimar Therapeutics
LRMR
$432M
$4K ﹤0.01%
+470
New +$5.15K

Similar funds

Victory Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Victory Capital Management held 3,834 positions worth $77.7B, up 57% from $49.6B the previous quarter. Its ten largest holdings account for 8% of the portfolio.

Victory Capital Management deployed $27.7B of net new capital in Q3 2019, opening 1,974 new positions and adding to 1,386 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,479,630 shares worth $316M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Reliance Steel & Aluminium, an estimated $98.7M trimmed.

  • Victory Capital Management's largest Q3 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,479,630 shares worth $316M.
  • Victory Capital Management added most to Microsoft in Q3 2019, an estimated $891M increase.
  • Victory Capital Management's biggest Q3 2019 reduction was Reliance Steel & Aluminium, cutting an estimated $98.7M.
  • Victory Capital Management fully exited Electronics for Imaging in Q3 2019, selling an estimated $61.5M.
  • Victory Capital Management's ten largest holdings make up 8% of its $77.7B portfolio in Q3 2019.
  • Victory Capital Management opened 1,974 new positions and closed 47 in Q3 2019.
  • Victory Capital Management's portfolio value rose 57% quarter-over-quarter to $77.7B.

Based on Victory Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.